Vyome Holdings (HIND) Cost of Revenue (2015 - 2026)
Vyome Holdings (HIND) reported Cost of Revenue of $15,297 for Q2 2026, down 40.5% from $25,719 a year earlier but up 2.3% from the prior quarter.
Powered by 
Analysis
Vyome Holdings (HIND) Cost of Revenue (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Vyome Holdings' Cost of Revenue came in at $61,305, down 47.1% year-over-year; for FY2025, it came in at $100,943, up 62.9% from FY2024.
- Cost of Revenue has a five-year compound annual growth rate of -54.3% (FY2020 to FY2025).
- By year, Cost of Revenue came in at $61,974 in FY2024 (-98.0%), $3.13 million in FY2023 (-29.5%), $4.44 million in FY2022 (-15.5%) and $5.25 million in FY2021 (+4.3%).
- Five-year quarterly Cost of Revenue spans a low of -$1,333 in Q4 2024 and a high of $1.57 million in Q3 2021.
- The high point for year-over-year Cost of Revenue in five years was Q1 2022 (growth of 30.4%); the low point was Q2 2025 (a decline of 96.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $14,946 (Q1 2026), $14,485 (Q4 2025) and $16,577 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Vyome Holdings | 13.41 Mn | -12.70 Mn | 11,658.00 | 15,297.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15,297.00 |
| Mar 31, 2026 | 14,946.00 |
| Dec 31, 2025 | 14,485.00 |
| Sep 30, 2025 | 16,577.00 |
| Jun 30, 2025 | 25,719.00 |
| Mar 31, 2025 | 44,162.00 |
| Dec 31, 2024 | -1,333.00 |
| Sep 30, 2024 | 47,441.00 |
| Jun 30, 2024 | 831,000.00 |
| Mar 31, 2024 | 779,000.00 |
| Dec 31, 2023 | 140,000.00 |
| Sep 30, 2023 | 867,000.00 |
| Jun 30, 2023 | 1.06 Mn |
| Mar 31, 2023 | 1.06 Mn |
| Dec 31, 2022 | 1.51 Mn |
| Sep 30, 2022 | 697,000.00 |
| Jun 30, 2022 | 1.01 Mn |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.37 Mn |
| Sep 30, 2021 | 1.57 Mn |
API Access
Vyome Holdings Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=HIND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "HIND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=HIND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();